# Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy

> **NCT02085239** · PHASE4 · WITHDRAWN · sponsor: **TriHealth Inc.**

## Conditions studied

- Pain Management After Breast Biopsy

## Interventions

- **DRUG:** Lidocaine Ropivacaine
- **DRUG:** Lidocaine alone

## Key facts

- **NCT ID:** NCT02085239
- **Lead sponsor:** TriHealth Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-08
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never got started; can't delete results
- **Last updated:** 2018-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02085239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02085239, "Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02085239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*